Aniket A Kawatkar

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. doi request reprint Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data
    Aniket A Kawatkar
    Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA 91101, USA
    Health Econ 22:807-23. 2013
  2. doi request reprint Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey
    Aniket A Kawatkar
    Southern California Permanente Medical Group, Pasadena, USA
    Arthritis Care Res (Hoboken) 64:1649-56. 2012
  3. doi request reprint Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients
    Li Hao Chu
    Southern California Permanente Medical Group, Pasadena, CA 91101, USA
    Arthritis Care Res (Hoboken) 65:299-303. 2013

Collaborators

Detail Information

Publications3

  1. doi request reprint Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data
    Aniket A Kawatkar
    Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA 91101, USA
    Health Econ 22:807-23. 2013
    ..The approach outlined in this article has broad application for comparative effectiveness and health technology assessment involving multiple treatments/interventions using real-world nonexperimental data...
  2. doi request reprint Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey
    Aniket A Kawatkar
    Southern California Permanente Medical Group, Pasadena, USA
    Arthritis Care Res (Hoboken) 64:1649-56. 2012
    ..To quantify the incremental direct medical expenditure associated with rheumatoid arthritis (RA) in the US population from a payer's perspective...
  3. doi request reprint Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients
    Li Hao Chu
    Southern California Permanente Medical Group, Pasadena, CA 91101, USA
    Arthritis Care Res (Hoboken) 65:299-303. 2013
    ..To assess racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs (DMARDs) among California Medicaid (Medi-Cal) rheumatoid arthritis (RA) patients...